Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,259 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Itching and treatments in atopic dermatitis (AD): results from the German AD registry TREATgermany.
Weisshaar E, Bentz P, Haufe E, Heinrich L, Apfelbacher C, Heratizadeh A, Abraham S, Harder I, Kleinheinz A, Wollenberg A, Schäkel K, Wiemers F, Ertner K, Augustin M, Wildberger J, von Kiedrowski R, Worm M, Zink A, Effendy I, Asmussen A, Pawlak M, Sticherling M, Hilgers M, Handrick C, Quist S, Schwarz B, Bell M, Staubach-Renz P, Hong-Weldemann SH, Homey B, Bruecher J, Weidinger S, Werfel T, Schmitt J; TREATgermany study group. Weisshaar E, et al. Among authors: schmitt j. Br J Dermatol. 2023 Feb 22;188(3):430-432. doi: 10.1093/bjd/ljac070. Br J Dermatol. 2023. PMID: 36763757 No abstract available.
Implementation of the HOME core outcome set for clinical trials of atopic eczema-barriers and opportunities: the HOME IX meeting report.
Jacobson ME, Thomas KS, Apfelbacher CJ, Leshem YA, Williams HC, Gerbens LAA, Spuls PI, Schmitt J, Howells L, Katoh N, Simpson EL; Harmonising Outcome Measures for Eczema (HOME) Initiative. Jacobson ME, et al. Among authors: schmitt j. Arch Dermatol Res. 2023 Nov;315(9):2617-2622. doi: 10.1007/s00403-023-02647-w. Epub 2023 Jul 11. Arch Dermatol Res. 2023. PMID: 37432466
Comment on: "Interim results from the PEDISTAD Real-World Registry by Paller et al"-First results from the German TREATkids registry for children and adolescents with moderate-to-severe atopic dermatitis.
Ott H, Abraham S, Kind B, Haufe E, Weidinger S, Werfel T, Schmitt J; TREATgermany Study Group. Ott H, et al. Among authors: schmitt j. J Am Acad Dermatol. 2024 Jan;90(1):e31-e33. doi: 10.1016/j.jaad.2023.08.092. Epub 2023 Sep 17. J Am Acad Dermatol. 2024. PMID: 37717725 No abstract available.
S3 guideline Atopic dermatitis: Part 2 - Systemic treatment.
Werfel T, Heratizadeh A, Aberer W, Augustin M, Biedermann T, Bauer A, Fölster-Holst R, Kahle J, Kinberger M, Nemat K, Neustädter I, Peters E, von Kiedrowski R, Schmid-Grendelmeier P, Schmitt J, Schwennesen T, Simon D, Spindler T, Traidl-Hoffmann C, Werner RN, Wollenberg A, Worm M, Ott H. Werfel T, et al. Among authors: schmitt j. J Dtsch Dermatol Ges. 2024 Feb;22(2):307-320. doi: 10.1111/ddg.15229. Epub 2023 Dec 31. J Dtsch Dermatol Ges. 2024. PMID: 38161245 Free article.
Stratum corneum and microbial biomarkers precede and characterize childhood atopic dermatitis.
Fonfara M, Hartmann J, Stölzl D, Sander N, Harder I, Rodriguez E, Hübenthal M, Mazur C, Kerzel S, Kabesch M, Schmitt J, Emmert H, Suhrkamp I, Weidinger S. Fonfara M, et al. Among authors: schmitt j. J Eur Acad Dermatol Venereol. 2024 Sep;38(9):1769-1775. doi: 10.1111/jdv.19932. Epub 2024 Feb 29. J Eur Acad Dermatol Venereol. 2024. PMID: 38421042 Clinical Trial.
Measuring appropriateness of diagnostic imaging: a scoping review.
Walther F, Eberlein-Gonska M, Hoffmann RT, Schmitt J, Blum SFU. Walther F, et al. Among authors: schmitt j. Insights Imaging. 2023 Apr 13;14(1):62. doi: 10.1186/s13244-023-01409-6. Insights Imaging. 2023. PMID: 37052758 Free PMC article. Review.
[No title available]
[No authors listed] [No authors listed] PMID: 38361206
Treatment of moderate-to-severe atopic dermatitis with baricitinib: Results from an interim analysis of the TREATgermany registry.
Traidl S, Heinrich L, Siegels D, Heratizadeh A, Kind B, Haufe E, Abraham S, Schäfer T, Augustin M, Harder I, Pinter A, Schäkel K, Wollenberg A, Ertner K, Ramaker-Brunke J, Bong A, Quist S, Gorriahn-Maiterth H, Schenck F, Sticherling M, Effendy I, Schwarz B, Handrick C, Asmussen A, Weidinger S, Schmitt J, Werfel T; TREATgermany study group. Traidl S, et al. Among authors: schmitt j. J Eur Acad Dermatol Venereol. 2024 Oct;38(10):e887-e891. doi: 10.1111/jdv.19979. Epub 2024 Mar 28. J Eur Acad Dermatol Venereol. 2024. PMID: 38545850 No abstract available.
Dupilumab but not cyclosporine treatment shifts the microbiome toward a healthy skin flora in patients with moderate-to-severe atopic dermatitis.
Hartmann J, Moitinho-Silva L, Sander N, Harder I, Häsler R, Rodriguez E, Haufe E, Kleinheinz A, Abraham S, Heratizadeh A, Weisshaar E, Schäkel K, Handrick C, Augustin M, Wollenberg A, Staubach-Renz P, Ertner K, Sticherling M, Schwarz B, Quist S, Wiemers F, Schenck F, Wildberger J, Tittmann L, Lieb W, Schmitt J, Werfel T, Weidinger S; TREATgermany Study Group. Hartmann J, et al. Among authors: schmitt j. Allergy. 2023 Aug;78(8):2290-2300. doi: 10.1111/all.15742. Epub 2023 Apr 18. Allergy. 2023. PMID: 37032440
2,259 results